ACTRN12612000527864尚未招募2 期
Men diagnosed with early stage prostate cancer and prescribed radiation therapy with or without neo-adjuvant androgen deprivation therapy will receive a specifically designed continence promotion intervention including a tailored pelvic floor muscle exercise program aimed at reducing lower urinary tract , lower bowel symptoms and erectile dysfunction
niversity of Newcastle0 个研究点目标入组 40 人开始时间: 2012年5月18日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 40 Years 至 90 Years（—）
- 性别
- Male
入选标准
- •Early stage prostate cancer
排除标准
- •Not fluent in English
- •Neurological conditions
- •Other bladder conditions
- •Secondary malignancies
- •Profoundly Deaf
- •Legally blind
- •Abdominal surgery in past 2 years
研究者
相似试验
招募中
不适用
PROCOG: Investigating Cognitive Problems in Men with Prostate CancerCognitive problemsCancer - ProstateMental Health - Studies of normal psychology, cognitive function and behaviourMental Health - AnxietyMental Health - DepressionMental Health - Other mental health disordersProstate CancerACTRN12621001608853Macquarie University150
招募中
不适用
The safety and efficacy of Irreversible Electroporation for the ablation of prostate cancer assessed by procedural related side effects and post prostatectomy histology: A pilot studyCancer - ProstateProstate cancerACTRN12612000523808Flack Trustees6
已完成
1 期
Radionuclide therapy using Lutetium-177 prostate specific membrane antigen (PSMA): a pilot study in men with castrate-resistant prostate cancer (LuPSMA trial)Cancer - ProstateProstate CancerACTRN12615000912583Peter MacCallum Cancer Centre30
招募中
Unknown
Detection of clinically significant prostate cancer with MRI-TRUS fusion image-guided biopsy: comparison of the evaluation system (PI-RADS category vs. PI-RADS + US evalutaion)Suspected prostate cancerJPRN-UMIN000050631Tokai University80
招募中
不适用
Prostate cancer background, QOL, patient's satisfaction and treatment survey by Japan Prostate Cancer Study GroupProstate cancerJPRN-UMIN000004666J-CaP study group10,000